Stoke Therapeutics (STOK) Earnings Date, Estimates & Call Transcripts $11.70 +0.17 (+1.47%) Closing price 06/16/2025 04:00 PM EasternExtended Trading$11.54 -0.15 (-1.32%) As of 07:10 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Stoke Therapeutics Earnings Summary Stoke Therapeutics posted Q4 2024 earnings on March 24, 2025, reporting an EPS of -$0.18, which beat the consensus estimate of -$0.56 by $0.38. Quarterly revenue was reported to be $22.61 million, above analysts' expectations of $4.20 million. With a trailing EPS of $0.79, Stoke Therapeutics' earnings are expected to decrease next year, from ($2.01) to ($2.27) per share. Upcoming Earnings DateAug. 5Before Market OpensEstimatedConsensus EPS (Mar. 24) -$0.56 Actual EPS (Mar. 24) -$0.18 Beat By $0.38 Actual Revenue (Mar. 24) $22.61MQ4 2024 Earnings ResourcesQ4 2024 Earnings Report Press Release (8-K) Annual Report (10-K)STOK Upcoming EarningsStoke Therapeutics' next earnings date is estimated for Tuesday, August 5, 2025, based on past reporting schedules. Powered by Get Stoke Therapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Stoke Therapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataSTOK Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.STOK Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Stoke Therapeutics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20253-$0.57-$0.49-$0.53Q2 20252-$0.68-$0.51-$0.60Q3 20253-$0.69-$0.58-$0.65Q4 20253-$0.79-$0.60-$0.70 FY 2025 11 -$2.73 -$2.18 -$2.47 Q1 20261-$0.64-$0.64-$0.64Q2 20261-$0.70-$0.70-$0.70Q3 20261-$0.73-$0.73-$0.73Q4 20261-$0.75-$0.75-$0.75 Stoke Therapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/5/2025(Estimated)--------3/24/2025Q4 2024-$0.56-$0.18+$0.38-$0.18$4.20M$22.61M11/5/2024--$0.52-$0.47+$0.05-$0.47$3.46M$4.89M8/7/2024--$0.57-$0.46+$0.11-$0.46$3.33M$4.83M5/6/2024Q1 2024-$0.60-$0.57+$0.03-$0.57$3.33M$4.22M3/25/2024Q4 2023-$0.62-$0.60+$0.02-$0.60$3.70M$2.80M11/7/2023Q3 2023-$0.65-$0.55+$0.10-$0.55$3.83M$3.31M8/7/2023Q2 2023-$0.63-$0.69 -$0.06-$0.69$4.00M-$2.48M Stoke Therapeutics Earnings - Frequently Asked Questions When is Stoke Therapeutics' earnings date? Stoke Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 5th, 2025 based off last year's report dates. Learn more on STOK's earnings history. Did Stoke Therapeutics beat their earnings estimates last quarter? In the previous quarter, Stoke Therapeutics (NASDAQ:STOK) reported ($0.18) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.56) by $0.38. Learn more on analysts' earnings estimate vs. STOK's actual earnings. How much revenue does Stoke Therapeutics generate each year? Stoke Therapeutics (NASDAQ:STOK) has a recorded annual revenue of $190.91 million. How much profit does Stoke Therapeutics generate each year? Stoke Therapeutics (NASDAQ:STOK) has a recorded net income of -$104.70 million. STOK has generated $0.79 earnings per share over the last four quarters. What is Stoke Therapeutics' EPS forecast for next year? Stoke Therapeutics' earnings are expected to decrease from ($2.01) per share to ($2.27) per share in the next year. More Earnings Resources from MarketBeat Related Companies Xenon Pharmaceuticals Earnings Date Amneal Pharmaceuticals Earnings Date Mirum Pharmaceuticals Earnings Date Arrowhead Pharmaceuticals Earnings Date NewAmsterdam Pharma Earnings Date Recursion Pharmaceuticals Earnings Date Kiniksa Pharmaceuticals Earnings Date Vericel Earnings Date Denali Therapeutics Earnings Date CG Oncology Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Broadcom Slides on Solid Earnings, AI Outlook Still StrongFive Below Pops on Strong Earnings, But Rally May StallRed Robin's Comeback: Q1 Earnings Spark Investor HopesOllie’s Q1 Earnings: The Good, the Bad, and What’s NextBroadcom Earnings Preview: AVGO Stock Near Record HighsUlta’s Beautiful Q1 Earnings Report Points to More Gains Aheade.l.f. Beauty Sees Record Surge After Earnings, Rhode Deal This page (NASDAQ:STOK) was last updated on 6/17/2025 by MarketBeat.com Staff From Our PartnersThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredBanks aren’t ready for this altcoin—are you?The Secret Crypto That Billionaires Are Hoarding When these hit, the current price will look like pocket ch...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Stoke Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Stoke Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy STOK Stock Free STOK Stock Alerts